Health Care

Remegen‑H (9995.HK) rises 2.62% as its HK$64.5 stock trades amid a 52‑week high of HK$123.1 – see market cap, volume and biotech focus on antibody therapies.

Pharmicell’s stem‑cell drugs face a 24‑hour dip; investors see a 17% drop month‑to‑date and a KRW 13,890 200‑day average as Cellgram‑AMI and other candidates vie for market share.

Top Glove Bhd stocks up 5.45%—SGD 0.29 per share, 18.37% YTD rise, 52‑week high at SGD 0.95. Explore why investors are buying gloves, rubber and more.

Immunovant stock falls 2.4% as analysts eye a modest quarterly loss, flat revenue forecasts, and a November earnings release.

Indoco Remedies stock at ₹219.5, trading 0.4% up—check its 200‑day SMA, 52‑week range, and market cap of ₹20.9 bn for a quick market snapshot.

Onconetix (ONCO) stock dips 54% last month, now trading at $0.42 with a $2.2M market cap—see recent price action and industry peers.

Sanigen (188260.KQ) trades flat at KRW 2,035, with a KRW 28.1 bn market cap and 13.9 mn shares—latest price, 200‑day SMA, and 52‑week highs and lows revealed.

Geninus stock drops 1.87%, now at KRW 1,393. Discover its market cap, 200‑day SMA, 52‑week highs/lows, and recent trade volume in this snapshot.

McKesson stock falls 1.14% to $991.4, trading below its 200‑day SMA while investors weigh recent 15% gains and a $116.7 bn market cap.

Tenaya Therapeutics stock: 24‑hour performance, price trends, market cap and key biotech insights for investors.